Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Aasly

Showing results (41-50 of 77) with videos related to

Pageof 8
Sort By:
Biomolecules|January 21, 2023
3α,7-Dihydroxy-14(13→12)<i>abeo</i>-5β,12α(H),13β(H)-cholan-24-oic Acids Display Neuroprotective Properties in Common Forms of Parkinson's DiseaseAndreas Luxenburger, Hannah Clemmens, Christopher Hastings, et al.
Journal of the Neurological Sciences|November 5, 2011
Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entityChristina Sundal, Jennifer Lash, Jan Aasly, et al.
Parkinsonism & Related Disorders|May 9, 2015
Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statementAndreas Puschmann, Laura Brighina, Katerina Markopoulou, et al.
Frontiers in Aging Neuroscience|October 16, 2023
Multifactorial assessment of Parkinson's disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort - extension of the LONG-PD studyBruce A Chase, Rejko Krueger, Lukas Pavelka, et al.
JAMA Neurology|November 18, 2014
Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysisIlir Agalliu, Marta San Luciano, Anat Mirelman, et al.
Neurogenetics|September 21, 2005
Lrrk2 pathogenic substitutions in Parkinson's diseaseIgnacio F Mata, Jennifer M Kachergus, Julie P Taylor, et al.
Neurogenetics|January 17, 2007
Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's diseaseJulie P Taylor, Mary M Hulihan, Jennifer M Kachergus, et al.
Neurobiology of Aging|September 18, 2013
Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from controlTessandra Stewart, Yu-Ting Sui, Luis F Gonzalez-Cuyar, et al.
Neurology|May 25, 2021
Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein-Containing Extracellular VesiclesZhen Hong, Chen Tian, Tessandra Stewart, et al.
Frontiers in Neurology|August 1, 2020
Longitudinal Monitoring of Parkinson's Disease in Different Ethnic Cohorts: The DodoNA and LONG-PD StudyKaterina Markopoulou, Jan Aasly, Sun Ju Chung, et al.
Pageof 8

Showing results (41-50 of 77) with videos related to

Sort By:
Pageof 8
Biomolecules|January 21, 2023
3α,7-Dihydroxy-14(13→12)<i>abeo</i>-5β,12α(H),13β(H)-cholan-24-oic Acids Display Neuroprotective Properties in Common Forms of Parkinson's DiseaseAndreas Luxenburger, Hannah Clemmens, Christopher Hastings, et al.
Journal of the Neurological Sciences|November 5, 2011
Hereditary diffuse leukoencephalopathy with axonal spheroids (HDLS): a misdiagnosed disease entityChristina Sundal, Jennifer Lash, Jan Aasly, et al.
Parkinsonism & Related Disorders|May 9, 2015
Clinically meaningful parameters of progression and long-term outcome of Parkinson disease: An international consensus statementAndreas Puschmann, Laura Brighina, Katerina Markopoulou, et al.
Frontiers in Aging Neuroscience|October 16, 2023
Multifactorial assessment of Parkinson's disease course and outcomes using trajectory modeling in a multiethnic, multisite cohort - extension of the LONG-PD studyBruce A Chase, Rejko Krueger, Lukas Pavelka, et al.
JAMA Neurology|November 18, 2014
Higher frequency of certain cancers in LRRK2 G2019S mutation carriers with Parkinson disease: a pooled analysisIlir Agalliu, Marta San Luciano, Anat Mirelman, et al.
Neurogenetics|September 21, 2005
Lrrk2 pathogenic substitutions in Parkinson's diseaseIgnacio F Mata, Jennifer M Kachergus, Julie P Taylor, et al.
Neurogenetics|January 17, 2007
Leucine-rich repeat kinase 1: a paralog of LRRK2 and a candidate gene for Parkinson's diseaseJulie P Taylor, Mary M Hulihan, Jennifer M Kachergus, et al.
Neurobiology of Aging|September 18, 2013
Cheek cell-derived α-synuclein and DJ-1 do not differentiate Parkinson's disease from controlTessandra Stewart, Yu-Ting Sui, Luis F Gonzalez-Cuyar, et al.
Neurology|May 25, 2021
Development of a Sensitive Diagnostic Assay for Parkinson Disease Quantifying α-Synuclein-Containing Extracellular VesiclesZhen Hong, Chen Tian, Tessandra Stewart, et al.
Frontiers in Neurology|August 1, 2020
Longitudinal Monitoring of Parkinson's Disease in Different Ethnic Cohorts: The DodoNA and LONG-PD StudyKaterina Markopoulou, Jan Aasly, Sun Ju Chung, et al.
Pageof 8